Siddharth Deshpande

Learn More
Background Lack of access to rabies immunoglobulin (RIG) contributes to the high rabies mortality. A recombinant human monoclonal antibody (SII RMAb) was tested in a post-exposure prophylaxis (PEP) regimen in comparison to a human RIG (HRIG)-containing PEP regimen. Methods This was a Phase 2/3 randomized, single blind, non-inferiority study conducted in(More)
  • 1